From Marcia Angell, Harvard Medical School….where is private industry with the drug companies fitting in? One thing they do, is perhaps step in with the the money to land the product to market, and the rest…well it’s up to each to assume their own opinion. BD
The problem with this sequence -- publicly-funded innovation handed off to the drug companies -- is that the industry expects to be rewarded as though it were the source of innovation, pricing drugs as high as the traffic will bear and doing everything possible to extend its exclusive marketing rights. The only really innovative thing about this industry today is the claims of its apologists.
0 comments :
Post a Comment